Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Supportive Cancer Therapy|July 17, 2008
Hemoglobin increase is associated with improved health-related quality of life in patients with cancer not receiving chemotherapyJr Robert E Smith, John A Glaspy, N Simon Tchekmedyian, et al.Oncology (Williston Park, N.Y.)|October 17, 2002
Psychological outcomes associated with anemia-related fatigue in cancer patientsJoel D Kallich, N Simon Tchekmedyian, Anne M Damiano, et al.European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
Effects of chemotherapy on endogenous erythropoietin levels and the pharmacokinetics and erythropoietic response of darbepoetin alfa: a randomised clinical trial of synchronous versus asynchronous dosing of darbepoetin alfaJohn Glaspy, David Henry, Ravi Patel, et al.Clinical Colorectal Cancer|May 29, 2007
Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancerJordan Berlin, James Posey, Simon Tchekmedyian, et al.Cancer|August 3, 2007
Panitumumab monotherapy in patients with previously treated metastatic colorectal cancerJ Randolph Hecht, Amita Patnaik, Jordan Berlin, et al.BMC Cancer|October 27, 2012
PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumoursMark J McKeage, Michael B Jameson, Ramesh K Ramanathan, et al.Journal of the National Cancer Institute|October 3, 2002
A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinomaFred Saad, Donald M Gleason, Robin Murray, et al.Journal of the National Cancer Institute|June 3, 2004
Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancerFred Saad, Donald M Gleason, Robin Murray, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study GroupLee S Rosen, David Gordon, Simon Tchekmedyian, et al.Cancer|June 16, 2004
Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trialLee S Rosen, David Gordon, N Simon Tchekmedyian, et al.Pageof 3